Cadralazine is a potent vasodilator with a primary indication for treating hypertension. Its mechanism of action involves the inhibition of calcium ion influx in smooth muscle cells, leading to vasodilation and reduced blood pressure. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Cadralazina, Cadral, Cadralazinum and Cadraten. Its PubChem CID is 2515.
Cadralazine
| CAS No | 64241-34-5 |
|---|---|
| Molecular Formula | C12H21N5O3 |
| Molecular Weight | 283.33 g/mol |
| Synonyms | ethyl N-[[6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl]amino]carbamate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Cadralazine is a potent vasodilator with a primary indication for treating hypertension. Its mechanism of action involves the inhibition of calcium ion influx in smooth muscle cells, leading to vasodilation and reduced blood pressure.
The listed CAS number is 64241-34-5.
The listed molecular formula is C12H21N5O3.
The listed molecular weight is 283.33 g/mol.
ethyl N-[[6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl]amino]carbamate.
The source lists Cadralazina, Cadral, Cadralazinum and Cadraten.